PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F08C8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $276,157
Award facts
- Contract value 100% obligated
- $276,157.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $276,157.43 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's parent company Cencora, Inc. (doing business as AmerisourceBergen). The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp maintains a significant position as a prime vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through competitive, open-market awards. The company's federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, diabetes treatments, neurological pharmaceuticals, pain management drugs, antibiotics, and medical supplies. The absence of set-aside designation reflects AmerisourceBergen's demonstrated ability to compete successfully against other qualified pharmaceutical distributors in full and open competition for critical federal medical supply requirements.
Quick answers
Who was awarded contract SPE2D826F08C8?
SPE2D826F08C8 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F08C8 worth?
The government has obligated $276,157 on SPE2D826F08C8.
Is contract SPE2D826F08C8 an order under another contract?
Yes. SPE2D826F08C8 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F08C8 competed?
The extent of competition for SPE2D826F08C8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award